Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 8;51(5):1428-1442.
doi: 10.1093/schbul/sbaf045.

Latent Trajectories of Positive, Negative Symptoms and Functioning in Early Intervention Services for First-Episode Psychosis: A 2-Year Follow-Up Study

Affiliations

Latent Trajectories of Positive, Negative Symptoms and Functioning in Early Intervention Services for First-Episode Psychosis: A 2-Year Follow-Up Study

Olivier Percie du Sert et al. Schizophr Bull. .

Abstract

Background: From the first episode (FEP), the course of psychosis is marked by substantial heterogeneity of clinical and functional outcomes which poses significant challenges in providing prognostic guidance to patients and families. To better understand such heterogeneity within the context of early intervention services (EIS), this study aimed to examine latent trajectories of positive and negative symptoms and functioning among FEP individuals undergoing EIS.

Study design: The Prevention and Early Intervention Program for Psychoses (PEPP-Montreal) is a 2-year EIS for FEP that conducted longitudinal assessments of 689 individuals aged 14-35, including sociodemographics, cognition, psychopathology, and functioning. Latent growth mixture modeling was used to identify distinct patterns of clinical and functional trajectories. The inter-relationship between trajectories, and the association of trajectory membership with baseline characteristics and distal outcomes were investigated using the manual 3-step approach.

Study results: Two positive symptom trajectories (Stable-low-32%, Fluctuating-68%,), 3 negative symptom trajectories (Decreasing-41%, Fluctuating-15%, and Stable-high-44%), and 2 functioning trajectories (Increasing-57%, Stable-moderate-43%) were identified. Early treatment response, particularly on negative symptoms, consistently and strongly predicted better outcome trajectories (OR = [3.4-5.5]). Trajectories of higher symptom severity were associated with trajectory of worse functioning (RR = [1.5-2.2]), which exhibited lower rates of clinical and functional remission.

Conclusion: These findings offer insights into clinically meaningful subgroups of individuals that could inform the prognosis of FEP and the development of individually tailored EIS. Individuals who do not show early improvement in negative symptoms may benefit from earlier psychosocial interventions specifically targeting actionable factors that contribute to secondary negative symptoms.

Keywords: data-driven; growth mixture modeling; heterogeneity; remission; schizophrenia; structural equation modeling.

PubMed Disclaimer

Conflict of interest statement

M.L. reports grants from Otsuka Lundbeck Alliance, and Roche, personal fees from Otsuka Canada, Lundbeck Canada, and Boehringer Ingelheim, as well as grants and personal fees from Janssen. A.M. and D.R.C. report no funding from industry in more than 3 years. R.J. reports grants, speaker honoraria, and honoraria from AstraZeneca, Janssen, Otsuka, Lundbeck, Pfizer Canada, BMS, Shire, and Sunovion, and royalties from Henry Stewart Talks. J.S. has received grants and salary awards from the Canadian Institutes of Health Research and Fonds de recherche du Québec–Santé, outside the submitted work. L.P. reports personal fees from Janssen Canada, Otsuka Canada, SPMM Course Limited, UK, Canadian Psychiatric Association; book royalties from Oxford University Press; and investigator-initiated educational grants from Sunovion, Janssen Canada, Otsuka Canada outside the submitted work. These interests had no relation to the present study. Other co-authors have no conflicts of interest to declare.

References

    1. Solmi M, Radua J, Olivola M, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27:281–295. - PMC - PubMed
    1. Crespo-Facorro B, Such P, Nylander AG, et al. The burden of disease in early schizophrenia—a systematic literature review. Curr Med Res Opin. 2021;37:109–121. - PubMed
    1. Birchwood M, Todd P, Jackson C. Early intervention in psychosis: the critical period hypothesis. Br J Psychiatry Suppl. 1998;172:53–59. - PubMed
    1. Harrison G, Hopper K, Craig T, et al. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry. 2001;178:506–517. - PubMed
    1. Bleuler M. The Schizophrenic Disorders: Long-Term Patient and Family Studies. New Haven, Connecticut, U.S: Yale University Press; 1978.